Suchergebnisse - "Dew, Alexander"

PubPharm (17)

1

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma : A Phase 2 Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2021

von Kazandjian, D. | Hill, E. | Dew, A. | +31

2

Diagnostic performance of 18 F-FDG-PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma : time to move forward

enthalten in: British journal of haematology | 2021

von Hill, E. | Mena, E. | Morrison, C. | +4

3

Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

enthalten in: The oncologist | 2021

von Kazandjian, D. | Dew, A. | Hill, E. | +19

4

Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models

enthalten in: JAMA oncology | 2021

von Hill, E. | Dew, A. | Morrison, C. | +4

5

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

enthalten in: The oncologist | 2021

von Kazandjian, D. | Dew, A. | Hill, E. | +19

6

The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies-back to the future!

enthalten in: Best practice & research. Clinical haematology | 2020

von Kazandjian, D. | Dew, A. | Hill, E.

7

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

enthalten in: Oral oncology | 2013

von Wong, S. | Campbell, B. | Massey, B. | +12

8

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

enthalten in: Oral oncology | 2013

von Wong, S. | Campbell, B. | Massey, B. | +12

9

Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial

enthalten in: Clinical trials (London, England) | 2013

von Dew, A. | Khan, S. | Babinski, C. | +7

10

Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial

enthalten in: Clinical trials | 2013

von Dew, A. | Khan, S. | Babinski, C. | +7